
Sign up to save your podcasts
Or


The biotech company, Valneva announced this month about the promising work and progress on two vaccine candidates--the mosquito borne virus, chikungunya and Lyme disease.
On today's show I am joined by Valneva President and CEO, Thomas Lingelbach to discuss the latest on these vaccine candidates.
By Robert Herriman4.2
1818 ratings
The biotech company, Valneva announced this month about the promising work and progress on two vaccine candidates--the mosquito borne virus, chikungunya and Lyme disease.
On today's show I am joined by Valneva President and CEO, Thomas Lingelbach to discuss the latest on these vaccine candidates.

2,060 Listeners

111,863 Listeners

368,887 Listeners

185 Listeners

28,912 Listeners

87 Listeners

2,474 Listeners

631 Listeners

0 Listeners

0 Listeners